Estimation of advanced glycation end products and advanced oxidation protein products;Stanovení produktů pokročilé glykace a oxidace

Klinicka Biochemie a Metabolismus

Volumn 10, Issue 1, 2002, Pages 11-16

  Kalousova M ^a   Zima, T ^a   Tesar V ^a   Skrha J ^a   Stipek S ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Advanced glycation end products (AGEs); Advanced oxidation protein products (AOPP); Carbonyl stress; Oxidative stress; Spectrofluorimetry; Spectrophotometry

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED OXIDATION PROTEIN PRODUCT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FLUORESCENCE; FLUOROMETRY; HEMODIALYSIS; HUMAN; MALE; OXIDATIVE STRESS; PROTEIN EXPRESSION; SPECTROFLUOROMETRY;

EID: 0036163298     PISSN: 12107921     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure
2. Autooxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia?
3. Advanced oxidation protein products as a novel marker of oxidative stress in uraemia
4. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications
5. Action des acides amines sur les sucres; formacion des melaniodines par voie methodique
6. Immunochemical detection of advanced glycosylation end products in vivo
7. New biomarkers of Maillard reaction damage to proteins
8. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept
9. Recent progress in advanced glycation end products and diabetic complications
10. Relevance of oxidative stress to long-term uremic complications
11. Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress?
12. Advanced oxidation protein products as novel molecular basis of oxidative stress in uraemia
13. Advanced oxidation protein products as novel mediator of inflammation and monocyte activation in chronic renal failure
14. Development of AGE- and AOPP- species in peritoneal dialysis fluids with low and high content of carbonyl stress compounds
15. Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies
16. Advanced glycated end- products (AGE) during haemodialysis treatment: Discrepant results with different methodologies reflecting the heterogenity of AGE compounds
17. Determination of advanced glycation and products in serum by fluorescence spectroscopy and competitive ELISA
18. Specific Fluorescence assay for advanced glycation end products in blood and urine of diabetic patients
19. Determination of vitamin A and E in serum and plasma using a simplified clarification method and high-performance liquid chromatography
20. Stanovení oxidovaného lipoproteinu nízké hustoty spektrofotometricky
21. Oxidative stress and diabetic vascular complications
22. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury
23. Economic analysis of tilizarad mesylate for aneurysmal subarachnoid hemorrage. Economic evaluation of a phase III clinical trial in Europe and Australia